Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Aterian NASDAQ ATER Prepares for Quarterly Earnings Report and Guidance

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finances
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Aterian (NASDAQ: ATER) is gearing up to unveil its latest quarterly earnings report on March 12, 2024. Market analysts are predicting that Aterian will reveal an earnings per share (EPS) of $-0.13. In the previous quarter, the company exceeded expectations by $0.05, leading to a 3.39% surge in the share price the following day.

On March 8, Aterian’s shares were trading at $0.4997, marking a significant 49.06% decline over the past year. Investors are eagerly awaiting to see if Aterian will not only surpass the projected EPS but also offer optimistic guidance for future growth. It’s important to recognize that the movement of stock prices post-earnings releases can be heavily influenced by guidance rather than simply meeting or missing earnings estimates.

CRBU Stock Update: March 11, 2024 – Slight Decline in Regular Trading Hours, Small Increase After-Hours Trading

On March 11, 2024, CRBU stock experienced a slight decline during regular trading hours but saw a small increase in after-hours trading. The stock closed at $7.22, which was a decrease of $0.20 or 2.70% from the previous market close. Despite the drop in price, CRBU is still trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been relatively stable over a longer period of time and may have some support at its current levels. After the market closed, CRBU saw a small uptick in price, rising $0.22 in after-hours trading. This could be a positive sign for investors, suggesting that there may be some buying interest in the stock at these levels. Overall, the performance of CRBU on March 11th was mixed, with a slight decline during regular trading hours followed by a small increase in after-hours trading. Investors will want to keep an eye on how the stock performs in the coming days to see if this upward momentum continues.

CRBU Stock Shows Strong Financial Growth in 2024: Revenue Surges, Net Loss Decreases

On March 11, 2024, CRBU stock showed significant improvements in its financial performance compared to the previous year and quarter. According to data from CNN Money, the company reported a total revenue of $13.85 million for the past year, which represents a 44.31% increase from the previous year. In the third quarter of the same year, CRBU’s total revenue surged to $23.66 million, marking a substantial 530.15% increase from the previous quarter.

Despite the impressive growth in revenue, CRBU also reported a net income loss of -$99.42 million for the past year. However, this figure represents a 48.56% decrease from the previous year. In the third quarter, the company managed to reduce its net income loss to -$10.00 million, which signifies a notable 66.12% improvement from the previous quarter.

Furthermore, CRBU’s earnings per share (EPS) also showed positive trends. The company reported an EPS of -$1.64 for the past year, reflecting a 47.25% decrease from the previous year. In the third quarter, CRBU’s EPS improved to -$0.12, indicating a significant 75.16% increase from the previous quarter.

Overall, CRBU’s stock performances on March 11, 2024, demonstrated strong growth in total revenue and net income, along with improvements in EPS. Investors may view these positive financial indicators as a sign of the company’s potential for future growth and profitability.

Tags: CRBU
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Fuel Tech Secures 21 Million in Air Pollution Control Contracts

Finance_ Investing in stocks

Monroe Capital Corporation Q4 Earnings Report Review

DrugRetailers Stock Market Today

Caseys General Stores Anticipates Growth Through Expansion Strategy

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com